It is expected that these increases in ISG induction during the early stages of infection would lead to increased clearance45, but questions remain about how exactly IFNλ3 and IFNλ4 induce differential antiviral activity as well as the kinetics of signaling and gene induction that govern these differences. The gene discussed is IFNL3; the disease is infection.